- Home
- SLNO vs SGRY Comparison
SLNO vs SGRY Comparison
Compare SLNO & SGRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLNO | SGRY |
|---|---|---|
| Founded | 1999 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.0B |
| IPO Year | 2014 | 2015 |
Fundamental Metrics
Financial Performance| Metric | SLNO | SGRY |
|---|---|---|
| Price | $34.16 | $12.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 8 |
| Target Price | ★ $108.00 | $22.25 |
| AVG Volume (30 Days) | 1.3M | ★ 2.0M |
| Earning Date | 05-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 108.90 | 54.14 |
| EPS | ★ 0.39 | N/A |
| Revenue | $1,450,788.00 | ★ $1,145,438,000.00 |
| Revenue This Year | $155.44 | $9.71 |
| Revenue Next Year | $57.99 | $7.82 |
| P/E Ratio | $94.31 | ★ N/A |
| Revenue Growth | ★ 138.82 | N/A |
| 52 Week Low | $32.63 | $12.25 |
| 52 Week High | $89.12 | $24.60 |
Technical Indicators
Market Signals| Indicator | SLNO | SGRY |
|---|---|---|
| Relative Strength Index (RSI) | 32.76 | 32.06 |
| Support Level | $32.63 | N/A |
| Resistance Level | $44.60 | $16.15 |
| Average True Range (ATR) | 2.45 | 0.75 |
| MACD | -0.18 | -0.24 |
| Stochastic Oscillator | 14.19 | 5.21 |
Price Performance
Historical ComparisonAbout SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
About SGRY Surgery Partners Inc.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.